INVA

Q: What is the price of Innoviva (INVA) today?

The current price of Innoviva (INVA) is $ 22.61, representing a 3.72% gain over the past year. The stock began the year trading around $ 19.99 and is currently priced at $ 22.61. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Innoviva (INVA) pay dividends?

Innoviva (INVA) did not pay dividends over the past year.

Q: Is Innoviva (INVA) a good investment?

Innoviva (INVA) is currently trading at $ 22.61 with a P/E ratio of 3.34. This represents a 1,314% premium compared to its historical average P/E. Over the past year, the stock has gained 3.72 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 3.72%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Innoviva Inc.

Price

$ 22.61

return (12m)

3.72%

p/e

3.34

p/bv

1.25

DIVIDEND YIELD

0.00%

INVA price

Innoviva

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment INVA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.91%

3 months

3.29%

1 year

3.72%

2 years

42.11%

5 years

69.62%

10 years

102.24%

Fundamentals INVA

review the fundamentals of Innoviva shares

P/E

3.34

Sector: -3.79 Industry: -3.79

P/S (PSR)

4.00

Sector: -4.18 Industry: -4.18

P/BV

1.25

Sector: 1.93 Industry: 1.93

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

27.46%

Sector: -65.66% Industry: -65.66%

ROE

37.59%

Sector: -66.61% Industry: -66.61%

ROIC

10.89%

Sector: -2,912.28% Industry: -2,912.28%

NET MARGIN

100.00%

Sector: -40.24% Industry: -40.24%

GROSS MARGIN

83.09%

Sector: 36.75% Industry: 36.75%

OPERATING MARGIN

38.15%

Sector: -39.10% Industry: -39.10%

EV/EBITDA

2.61

Sector: -3.88 Industry: -3.88

EV/EBIT

2.73

Sector: -3.97 Industry: -3.97

PRICE-TO-ASSETS

0.92

Sector: 1.41 Industry: 1.41

BVPS

18.13

Sector: 1.86 Industry: 1.86

EPS

6.82

Sector: -2.14 Industry: -2.14

EQUITY-TO-ASSETS RATIO

0.73

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.27

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

1.43%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

13.66%

Sector: - Industry: -

FAIR VALUE OF Innoviva ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 22.61

Fair Value

$ 52.75

Upside Return potential.

133.28%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals INVA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	27.58	7.15	25.92%	2.18%	$ 580.26 B	21.83%
PFE	19.91	1.65	8.29%	6.56%	$ 149.16 B	11.83%
ABBV	110.89	-60.96	-54.98%	2.96%	$ 403.08 B	5.79%
NVO	65.46	40.20	61.41%	4.25%	$ 195.21 B	37.07%
MRK	32.94	6.41	19.45%	2.79%	$ 294.29 B	13.59%
AZN	26.65	5.84	21.93%	1.79%	$ 276.88 B	17.19%
GILD	16.93	6.66	39.33%	2.54%	$ 155.98 B	30.99%
BMY	16.00	5.79	36.19%	4.38%	$ 116.43 B	15.01%
ZTS	12.70	10.39	81.75%	2.59%	$ 33.58 B	27.79%
REGN	14.39	2.03	14.08%	0.59%	$ 63.66 B	29.65%
HALO	23.51	37.34	158.82%	0.00%	$ 8.20 B	23.13%
AMGN	24.59	20.87	84.87%	2.76%	$ 191.81 B	20.96%
MCK	20.09	-114.69	-570.98%	0.40%	$ 95.65 B	1.18%
HRMY	13.72	2.20	16.00%	0.00%	$ 2.00 B	16.20%
VRTX	26.05	5.84	22.41%	0.00%	$ 113.01 B	35.51%
CAH	33.83	-19.69	-58.20%	0.91%	$ 52.60 B	0.62%
ADMA	11.72	4.96	42.37%	0.00%	$ 1.94 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

INVA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/08/2015	09/30/2015	0,25000000
Dividends	06/10/2015	06/30/2015	0,25000000
Dividends	03/10/2015	03/31/2015	0,25000000
Dividends	11/21/2014	12/23/2014	0,25000000
Dividends	08/26/2014	09/18/2014	0,25000000

ABOUT Innoviva

Innoviva Inc.

Average Investor10 user rating

4.0 (1 people)

United States

30 years

Founded: 1996

2004

Time since IPO - 22 years

5

Employees

Innoviva Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.68 Billion, with shareholders equity totaling $1.34 Billion.

The company employs approximately 5 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Innoviva Inc. reported $420.68 Millions in revenue, generating net income of $504.34 Millions.

Key financial metrics include a P/E ratio of 3.34, a price-to-book (P/B) ratio of 1.25, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker INVA.

Market cap

$ 1.68 Billion

Net worth

$ 1.34 Billion

$ 1,341,650,000.00

Assets

$ 1.84 Billion

$ 1,836,590,000.00

Total Shares Outstanding

74.00 Millions

74,000,000

Average Daily Trading Volume

$ 734.27 Thousand

$ 734,272.00

Sector

Health Care

Industry

Biotechnology

INVA

INVA revenue and profits

Financial Results INVA

DRAG THE FRAME TO SEE MORE DATA

INVA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 785.43 8,98% (12M)

P/E

20.09

0.40%

ROE

-570.98%

P/BV

-114.69

CAH - Cardinal Health

$ 227.72 39,98% (12M)

P/E

33.83

0.91%

ROE

-58.20%

P/BV

-19.69

JNJ - Johnson & Johnson

$ 235.18 58,21% (12M)

P/E

27.58

2.18%

ROE

25.92%

P/BV

7.15

MRK - Merck & Co.

$ 115.17 53,52% (12M)

P/E

32.94

2.79%

ROE

19.45%

P/BV

6.41

AZN - AstraZeneca

$ 178.76 28,53% (12M)

P/E

26.65

1.79%

ROE

21.93%

P/BV

5.84

ABBV - AbbVie

$ 222.47 23,75% (12M)

P/E

110.89

2.96%

ROE

-54.98%

P/BV

-60.96

PFE - Pfizer

$ 26.04 16,11% (12M)

P/E

19.91

6.56%

ROE

8.29%

P/BV

1.65

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 785.43 8,98% (12 M)

P/L

20.09

0.40%

ROE

-570.98%

P/VP

-114.69

CAH - Cardinal Health

$ 227.72 39,98% (12 M)

P/L

33.83

0.91%

ROE

-58.20%

P/VP

-19.69

JNJ - Johnson & Johnson

$ 235.18 58,21% (12 M)

P/L

27.58

2.18%

ROE

25.92%

P/VP

7.15

MRK - Merck & Co.

$ 115.17 53,52% (12 M)

P/L

32.94

2.79%

ROE

19.45%

P/VP

6.41

AZN - AstraZeneca

$ 178.76 28,53% (12 M)

P/L

26.65

1.79%

ROE

21.93%

P/VP

5.84

ABBV - AbbVie

$ 222.47 23,75% (12 M)

P/L

110.89

2.96%

ROE

-54.98%

P/VP

-60.96

PFE - Pfizer

$ 26.04 16,11% (12 M)

P/L

19.91

6.56%

ROE

8.29%

P/VP

1.65

Frequently Asked Questions

What is the price of Innoviva (INVA) today?

The current price of Innoviva (INVA) is $ 22.61, representing a 3.72% gain over the past year. The stock began the year trading around $ 19.99 and is currently priced at $ 22.61. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Innoviva (INVA) pay dividends?

Innoviva (INVA) did not pay dividends over the past year.

Is Innoviva (INVA) a good investment?

Innoviva (INVA) is currently trading at $ 22.61 with a P/E ratio of 3.34. This represents a 1,314% premium compared to its historical average P/E. Over the past year, the stock has gained 3.72 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 3.72%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Innoviva (INVA) stock?

You can buy Innoviva (INVA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol INVA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Innoviva (INVA) yield today?

Over the past month, Innoviva (INVA) has returned 2.91% — 3.72% over the past year, and 69.62% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Innoviva (INVA) today at the current price of $ 22.61 your total investment would be $ 2,261.00.

Based on historical performance, the investment would have grown to approximately:

$ 2,345.11 after 1 year
$ 3,835.11 after 5 years
$ 4,572.65 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

INVA

Innoviva Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment INVA

review the fundamentals of Innoviva shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Innoviva

Innoviva Inc.

United States

30 years

2004

5

PROFIT X PRICE INVA

Financial Results INVA

INVA cash flow

Asset, Revenue and Profit Growth - INVA

INVA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

Frequently Asked Questions